• Table of Contents • cen-chemjobs.org • Today's Headlines • Editor's Page • Business • Government & Policy • Science & Technology • ACS News • Calendars • Books • Career & Employment • Special Reports • Nanotechnology • What's That Stuff?          Back Issues 2003 2002 2001 2000 1999 1998  Safety Letters  Chemcyclopedia ACS Members can sign up to receive C&EN e-mail newsletter.   Join ACS			March 24, 2003 Volume 81, Number 12 CENEAR 81 12 p. 10 ISSN 0009-2347 JOURNAL PUBLISHING Gordon Amidon Will Edit New ACS Journal, Molecular Pharmaceutics SOPHIE WILKINSON Amidon U OF MICHIGAN COLLEGE OF PHARMACY The American Chemical Society announced this week that it will introduce its 32nd journal, Molecular Pharmaceutics, early in 2004. Gordon L. Amidon, who is Charles R. Walgreen Jr. Professor of Pharmacy and professor of pharmaceutical sciences at the University of Michigan, Ann Arbor, will serve as editor of the new bimonthly. Amidon says the journal will concentrate on "the rapidly advancing molecular and mechanistic research in the pharmaceutical and biopharmaceutical fields. The journal will have a distinct molecular and mechanistic focus emphasizing the chemistry of drug delivery." Possible subjects include drug and delivery system properties, drug transport and metabolism processes, and enzyme and transporter targets for drug delivery and targeting. John P. Ochs, director of new product development for ACS's Publications Division, says Amidon "has worked broadly in the chemical and chemical biological sciences in drug delivery and has an extensive research background in molecular aspects of pharmaceutics and biopharmaceutics." Amidon earned a Ph.D. in pharmaceutical chemistry in 1971 from the University of Michigan. He was president of the American Association of Pharmaceutical Scientists in 1998 and is a fellow of the American Association for the Advancement of Science. He has served on editorial boards of numerous pharmaceutical journals. Amidon is chairman of drug delivery company PORT Systems and chairman and chief scientific officer of pharmaceutical product development firm TSRL. Top Chemical & Engineering News Copyright © 2003 American Chemical Society			Advanced Options Related Person Gordon L. Amidon E-mail this article to a friend Print this article E-mail the editor
	Home | Table of Contents | Today's Headlines | Business | Government & Policy | Science & Technology | C&EN Classifieds
	About C&EN | How To Reach Us | How to Advertise | Editorial Calendar | Email Webmaster

Chemical & Engineering News Copyright © 2003 American Chemical Society. All rights reserved. • (202) 872-4600 • (800) 227-5558